Literature DB >> 12270333

Alendronate increases bone mineral density in long-term renal transplant recipients.

M Koc1, S Tuglular, H Arikan, C Ozener, E Akoglu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12270333     DOI： 10.1016/s0041-1345(02)02872-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Renale osteodystrophie.

Authors:  Daniel Cejka
Journal:  Wien Med Wochenschr       Date:  2013-05-09

2.  Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease.

Authors:  Sakura Yamamoto; Atsushi Suzuki; Hitomi Sasaki; Sahoko Sekiguchi-Ueda; Shogo Asano; Megumi Shibata; Nobuki Hayakawa; Shuji Hashimoto; Kiyotaka Hoshinaga; Mitsuyasu Itoh
Journal:  J Bone Miner Metab       Date:  2012-10-18       Impact factor: 2.626

Review 3.  Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.

Authors:  J Wang; M Yao; J-h Xu; B Shu; Y-j Wang; X-j Cui
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

4.  Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.

Authors:  F P Tillmann; M Schmitz; M Jäger; R Krauspe; L C Rump
Journal:  Int Urol Nephrol       Date:  2015-10-26       Impact factor: 2.370

Review 5.  Interventions for preventing bone disease in kidney transplant recipients.

Authors:  Suetonia C Palmer; Edmund Ym Chung; David O McGregor; Friederike Bachmann; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

6.  Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Yan Yang; Shi Qiu; Xi Tang; Xin-Rui Li; Ling-Hui Deng; Qiang Wei; Ping Fu
Journal:  Chin Med J (Engl)       Date:  2018-04-05       Impact factor: 2.628

7.  Effect of Bisphosphonates on Bone Health in Adult Renal Transplant Patients: Beyond the First Year Posttransplant-A Systematic Review and Meta-Analysis.

Authors:  Alyssa Lip; Ashley Warias; M Khaled Shamseddin; Benjamin Thomson; D Thiwanka Wijeratne
Journal:  Can J Kidney Health Dis       Date:  2019-06-25

Review 8.  Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.

Authors:  Shun-Li Kan; Guang-Zhi Ning; Ling-Xiao Chen; Yong Zhou; Jing-Cheng Sun; Shi-Qing Feng
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.

Authors:  Yan Yang; Shi Qiu; Linghui Deng; Xi Tang; Xinrui Li; Qiang Wei; Ping Fu
Journal:  BMC Nephrol       Date:  2018-10-19       Impact factor: 2.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.